These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
631 related articles for article (PubMed ID: 32367746)
1. ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use During the Pandemic: The Pediatric Perspective. South AM; Brady TM; Flynn JT Hypertension; 2020 Jul; 76(1):16-22. PubMed ID: 32367746 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019. Sanchis-Gomar F; Lavie CJ; Perez-Quilis C; Henry BM; Lippi G Mayo Clin Proc; 2020 Jun; 95(6):1222-1230. PubMed ID: 32376099 [TBL] [Abstract][Full Text] [Related]
4. Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers. Danser AHJ; Epstein M; Batlle D Hypertension; 2020 Jun; 75(6):1382-1385. PubMed ID: 32208987 [TBL] [Abstract][Full Text] [Related]
5. The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19. Tsioufis C; Dimitriadis K; Tousoulis D Hellenic J Cardiol; 2020; 61(1):31-33. PubMed ID: 32450334 [No Abstract] [Full Text] [Related]
6. Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients. Rossi GP; Sanga V; Barton M Elife; 2020 Apr; 9():. PubMed ID: 32250244 [TBL] [Abstract][Full Text] [Related]
7. Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2. Young MJ; Clyne CD; Chapman KE J Endocrinol; 2020 Nov; 247(2):R45-R62. PubMed ID: 32966970 [TBL] [Abstract][Full Text] [Related]
8. Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week. Brojakowska A; Narula J; Shimony R; Bander J J Am Coll Cardiol; 2020 Jun; 75(24):3085-3095. PubMed ID: 32305401 [TBL] [Abstract][Full Text] [Related]
9. Covid-19: the renin-angiotensin system imbalance hypothesis. Lanza K; Perez LG; Costa LB; Cordeiro TM; Palmeira VA; Ribeiro VT; Simões E Silva AC Clin Sci (Lond); 2020 Jun; 134(11):1259-1264. PubMed ID: 32507883 [TBL] [Abstract][Full Text] [Related]
10. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury. Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866 [TBL] [Abstract][Full Text] [Related]
11. Discovery and characterization of ACE2 - a 20-year journey of surprises from vasopeptidase to COVID-19. Hooper NM; Lambert DW; Turner AJ Clin Sci (Lond); 2020 Sep; 134(18):2489-2501. PubMed ID: 32990314 [TBL] [Abstract][Full Text] [Related]
12. Correlation between renin-angiotensin system and Severe Acute Respiratory Syndrome Coronavirus 2 infection: What do we know? Vitiello A; Ferrara F Eur J Pharmacol; 2020 Sep; 883():173373. PubMed ID: 32679185 [TBL] [Abstract][Full Text] [Related]
13. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. Vaduganathan M; Vardeny O; Michel T; McMurray JJV; Pfeffer MA; Solomon SD N Engl J Med; 2020 Apr; 382(17):1653-1659. PubMed ID: 32227760 [No Abstract] [Full Text] [Related]
14. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy. Datta PK; Liu F; Fischer T; Rappaport J; Qin X Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005 [TBL] [Abstract][Full Text] [Related]
15. Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence. Turgeon RD; Zieroth S; Bewick D; Chow CM; Clarke B; Cowan S; Fordyce CB; Fournier A; Gin K; Gupta A; Hardiman S; Jackson S; Lau B; Leong-Poi H; Mansour S; Marelli A; Quraishi AR; Roifman I; Ruel M; Sapp J; Singh G; Small G; Virani S; Wood DA; Krahn A Can J Cardiol; 2020 Aug; 36(8):1180-1182. PubMed ID: 32502522 [No Abstract] [Full Text] [Related]
16. Two hits to the renin-angiotensin system may play a key role in severe COVID-19. Tseng YH; Yang RC; Lu TS Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy. Chung MK; Karnik S; Saef J; Bergmann C; Barnard J; Lederman MM; Tilton J; Cheng F; Harding CV; Young JB; Mehta N; Cameron SJ; McCrae KR; Schmaier AH; Smith JD; Kalra A; Gebreselassie SK; Thomas G; Hawkins ES; Svensson LG EBioMedicine; 2020 Aug; 58():102907. PubMed ID: 32771682 [TBL] [Abstract][Full Text] [Related]
18. COVID-19, ACE2, and the cardiovascular consequences. South AM; Diz DI; Chappell MC Am J Physiol Heart Circ Physiol; 2020 May; 318(5):H1084-H1090. PubMed ID: 32228252 [TBL] [Abstract][Full Text] [Related]
19. Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19. Wysocki J; Lores E; Ye M; Soler MJ; Batlle D J Am Soc Nephrol; 2020 Sep; 31(9):1941-1943. PubMed ID: 32669323 [No Abstract] [Full Text] [Related]
20. Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2). Zemlin AE; Wiese OJ Ann Clin Biochem; 2020 Sep; 57(5):339-350. PubMed ID: 32369402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]